Drug
Metadoxine
Metadoxine is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
25%
Ph phase_2
2
50%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
Withdrawn1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (50.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
Trials by Status
withdrawn125%
completed250%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
withdrawnphase_3
Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis
NCT02541045
unknownphase_4
Effect of Metadoxine on Oxidative Stress in Non-alcoholic Hepatic Steatosis
NCT02051842
completedphase_2
A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease
NCT01504295
completedphase_2
Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis
NCT02019056
Clinical Trials (4)
Showing 4 of 4 trials
NCT02541045Phase 3
Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis
NCT02051842Phase 4
Effect of Metadoxine on Oxidative Stress in Non-alcoholic Hepatic Steatosis
NCT01504295Phase 2
A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease
NCT02019056Phase 2
Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4